{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T23:41:43Z","timestamp":1773963703447,"version":"3.50.1"},"reference-count":29,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2016,2,8]],"date-time":"2016-02-08T00:00:00Z","timestamp":1454889600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004423","name":"World Health Organization","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004423","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Influenza Resp Viruses"],"published-print":{"date-parts":[[2016,7]]},"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>A modelling study was conducted to determine the effectiveness of trivalent (<jats:styled-content style=\"fixed-case\">TIV<\/jats:styled-content>) and quadrivalent (<jats:styled-content style=\"fixed-case\">QIV<\/jats:styled-content>) vaccination in South Africa and Australia.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objectives<\/jats:title><jats:p>This study aimed to determine the potential benefits of alternative vaccination strategies which may depend on community\u2010specific demographic and health characteristics.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Two influenza A and two influenza B strains were simulated using individual\u2010based simulation models representing specific communities in South Africa and Australia over 11 years. Scenarios using <jats:styled-content style=\"fixed-case\">TIV<\/jats:styled-content> or <jats:styled-content style=\"fixed-case\">QIV<\/jats:styled-content>, with alternative prioritisation strategies and vaccine coverage levels, were evaluated using a country\u2010specific health outcomes process.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In South Africa, approximately 18% fewer deaths and hospitalisations would be expected to result from the use of <jats:styled-content style=\"fixed-case\">QIV<\/jats:styled-content> compared to <jats:styled-content style=\"fixed-case\">TIV<\/jats:styled-content> over the 11 modelled years (<jats:italic>P<\/jats:italic> = 0\u00b7031). In Australia, only 2% (<jats:italic>P<\/jats:italic> = 0\u00b730) fewer deaths and hospitalisations would result. Vaccinating 2%, 5%, 15% or 20% of the population with <jats:styled-content style=\"fixed-case\">TIV<\/jats:styled-content> using a strategy of prioritising vulnerable age groups, including <jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content>\u2010positive individuals, resulted in reductions in hospitalisations and mortality of at least 7%, 18%, 57% and 66%, respectively, in both communities.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The degree to which <jats:styled-content style=\"fixed-case\">QIV<\/jats:styled-content> can reduce health burden compared to <jats:styled-content style=\"fixed-case\">TIV<\/jats:styled-content> is strongly dependent on the number of years in which the influenza B lineage in the <jats:styled-content style=\"fixed-case\">TIV<\/jats:styled-content> matches the circulating B lineages. Assuming a moderate level of B cross\u2010strain protection, <jats:styled-content style=\"fixed-case\">TIV<\/jats:styled-content> may be as effective as <jats:styled-content style=\"fixed-case\">QIV<\/jats:styled-content>. The choice of vaccination prioritisation has a greater impact than the <jats:styled-content style=\"fixed-case\">QIV<\/jats:styled-content>\/<jats:styled-content style=\"fixed-case\">TIV<\/jats:styled-content> choice, with strategies targeting those most responsible for transmission being most effective.<\/jats:p><\/jats:sec>","DOI":"10.1111\/irv.12367","type":"journal-article","created":{"date-parts":[[2015,12,12]],"date-time":"2015-12-12T15:15:40Z","timestamp":1449933340000},"page":"324-332","source":"Crossref","is-referenced-by-count":15,"title":["Trivalent and quadrivalent influenza vaccination effectiveness in Australia and South Africa: results from a modelling study"],"prefix":"10.1111","volume":"10","author":[{"given":"George J.","family":"Milne","sequence":"first","affiliation":[{"name":"School of Computer Science and Software Engineering University of Western Australia Perth WA Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nilimesh","family":"Halder","sequence":"additional","affiliation":[{"name":"School of Computer Science and Software Engineering University of Western Australia Perth WA Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9814-6435","authenticated-orcid":false,"given":"Joel K.","family":"Kelso","sequence":"additional","affiliation":[{"name":"School of Computer Science and Software Engineering University of Western Australia Perth WA Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian G.","family":"Barr","sequence":"additional","affiliation":[{"name":"World Health Organization (WHO) Collaborating Centre for Reference and Research on Influenza Melbourne Vic. Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jocelyn","family":"Moyes","sequence":"additional","affiliation":[{"name":"Centre for Respiratory Disease and Meningitis National Institute for Communicable Diseases Johannesburg South Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen","family":"Kahn","sequence":"additional","affiliation":[{"name":"MRC\/Wits Rural Public Health and Health Transitions Research Unit (Agincourt) Faculty of Health Science School of Public Health University of the Witwatersrand Johannesburg South Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rhian","family":"Twine","sequence":"additional","affiliation":[{"name":"MRC\/Wits Rural Public Health and Health Transitions Research Unit (Agincourt) Faculty of Health Science School of Public Health University of the Witwatersrand Johannesburg South Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheryl","family":"Cohen","sequence":"additional","affiliation":[{"name":"Centre for Respiratory Disease and Meningitis National Institute for Communicable Diseases Johannesburg South Africa"},{"name":"Faculty of Health Science School of Public Health University of the Witwatersrand Johannesburg South Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2016,2,8]]},"reference":[{"key":"e_1_2_9_2_1","unstructured":"World Health Organisation.Influenza (seasonal) fact sheet no 211 March 2014.2014. Available athttp:\/\/www.who.int\/mediacentre\/factsheets\/fs211\/en\/(Accessed 7 November 2014)."},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu095"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1086\/657314"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.3201\/eid1911.130546"},{"key":"e_1_2_9_6_1","volume-title":"2009 Adult Vaccination Survey: Summary of Results","author":"Australian Institute of Health and Welfare","year":"2011"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(14)70034-7"},{"key":"e_1_2_9_8_1","unstructured":"US Centers for Disease Control.Influenza vaccination coverage trends 1989\u20132008 (NHIS).2008. Available athttp:\/\/www.cdc.gov\/flu\/pdf\/professionals\/nhis89_08fluvaxtrendtab.pdf(Accessed 26 May 2015)."},{"key":"e_1_2_9_9_1","unstructured":"WHO.WHO recommendations on the composition of influenza virus vaccines.2014. Available athttp:\/\/www.who.int\/influenza\/vaccines\/virus\/recommendations\/en\/(Accessed 7 November 2014)."},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kws121"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1750-2659.2011.00302.x"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1586\/14737167.2014.908713"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.2165\/11641110-000000000-00000"},{"key":"e_1_2_9_14_1","unstructured":"EnglandPH.(Archived content) HPA \u2013 HPA National influenza annual reports.2012. Available athttp:\/\/webarchive.nationalarchives.gov.uk\/20140629102627\/http:\/\/hpa.org.uk\/Topics\/InfectiousDiseases\/InfectionsAZ\/SeasonalInfluenza\/EpidemiologicalData\/07influsInfluenzaannualreports\/(Accessed 11 November 2014)."},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jis575"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2013.07.018"},{"key":"e_1_2_9_17_1","first-page":"CD001269","article-title":"Vaccines for preventing influenza in healthy adults","volume":"7","author":"Jefferson T","year":"2010","journal-title":"Cochrane Libr"},{"key":"e_1_2_9_18_1","volume-title":"Influenza\u2010Associated Morbidity and Mortality in South Africa","author":"Cohen C","year":"2014"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiu647"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiu048"},{"key":"e_1_2_9_21_1","unstructured":"National Health Service (United Kingdom).Children's flu vaccine \u2013 vaccination \u2013 NHS choices.2015. Available athttp:\/\/www.nhs.uk\/conditions\/vaccinations\/pages\/child-flu-vaccine.aspx(Accessed 9 September 2015)."},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.12.098"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0098437"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.3111\/13696998.2015.1044456"},{"key":"e_1_2_9_25_1","first-page":"140","volume-title":"4Flu \u2013 An Individual Based Simulation Tool to Study the Effects of Vaccination on Seasonal Influenza in Germany","author":"Eichner M","year":"2013"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-14-365"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature01509"},{"key":"e_1_2_9_28_1","doi-asserted-by":"crossref","DOI":"10.2807\/ese.14.40.19354-en","article-title":"Does viral interference affect spread of influenza","volume":"14","author":"Linde A","year":"2009","journal-title":"Euro Surveill"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1097\/EDE.0b013e31826b300e"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.1099\/vir.0.000156"}],"container-title":["Influenza and Other Respiratory Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Firv.12367","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/irv.12367","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/irv.12367","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/irv.12367","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T17:55:43Z","timestamp":1695750943000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/irv.12367"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,8]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["10.1111\/irv.12367"],"URL":"https:\/\/doi.org\/10.1111\/irv.12367","archive":["Portico"],"relation":{},"ISSN":["1750-2640","1750-2659"],"issn-type":[{"value":"1750-2640","type":"print"},{"value":"1750-2659","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,8]]}}}